Company intelligence / Profile preview

Perora GmbH

Heidelberg, Baden-Württemberg, Germanydnb.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Perora has developed a proprietary polymer-based platform technology aimed at reducing caloric absorption from food via oral administration. Their lead program targets obesity and type II diabetes with non-invasive devices and supplements. The company has brought at least one product, REDIA, to market for dietary management of diabetes type II. Early clinical results are described as encouraging; further validation was planned following seed investment in 2013–2014.

Therapeutic areas: Endocrinology
Modalities: Polymer-based medical devicesdietary fiber supplementperoral nutrient neutralizers (PNNs)
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

REDIA

Commercial

Indications: Type 2 diabetes

1 more asset in the full pipeline.

Request access →

Partnerships

High-Tech Gründerfonds (HTGF) – lead investor and strategic partner during seed round funding [2013–14].

Beyond the preview

Go deeper on Perora GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perora GmbH.

Explore the full profile